What does Tranylcypromine (Parnate) do in plain English—and how does it work inside your body?
Tranylcypromine is an FDA-regulated Monoamine Oxidase Inhibitor (RxNorm RxCUI 313447). Mechanistically, 12.1 Mechanism of Action The mechanism of action of tranylcypromine tablets as an antidepressant is not fully understood, but is presumed to be linked to potentiation of monoamine neurotransmitter activity in the central nervous system (CNS) resulting from its irreversible inhibition of the enzyme monoamine oxidase (MAO). [1][2].
When your doctor writes a prescription for Tranylcypromine (RxNorm RxCUI 313447, also dispensed under brand names including Parnate), the goal is to target the root physiological pathway driving your condition rather than just masking surface symptoms [1]. According to the official FDA DailyMed package insert, 12.1 Mechanism of Action The mechanism of action of tranylcypromine tablets as an antidepressant is not fully understood, but is presumed to be linked to potentiation of monoamine neurotransmitter activity in the central nervous system (CNS) resulting from its irreversible inhibition of the enzyme monoamine oxidase (MAO). [2].
Across real-world patient logs on dotMD (92% positive worth-it rating), patients do best when they understand both what the medication is doing on day 1 and how long it takes to reach steady-state protection [3].
Check the imprint code on your Tranylcypromine tablet bottle and confirm with your pharmacist that it matches your prescribed strength (10 mg/1 Tablet, 10mg Tablet).